Telomeres Parameters in Celiac Disease
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
Celiac disease is an autoimmune process that causes destructive changes in the epithel of the small bowel and it is also a pre-malignant state (e.g lymphoma). The aim of the study is to examine telomere length and other parameters of genetic instability from peripheral blood lymphocytes of patients with celiac disease compared with healthy controls.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 27, 2014
CompletedFirst Posted
Study publicly available on registry
April 29, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedApril 29, 2014
April 1, 2014
April 27, 2014
April 27, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
telomere length
at entry, after 6 months of gluten-free diet
Study Arms (1)
celiac disease
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- patients with celiac disease
You may not qualify if:
- known malignancy
- cannot sign informed consent
- under age 18
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- physician in gastroenterlogy institute
Study Record Dates
First Submitted
April 27, 2014
First Posted
April 29, 2014
Primary Completion
December 1, 2015
Last Updated
April 29, 2014
Record last verified: 2014-04